In the phase 3 ACTG A5359 LATITUDE trial, investigators evaluated whether monthly, long-acting injectable cabotegravir plus rilpivirine could reduce regimen failure compared with standard oral...
On March 3, 2026, the FDA approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 mcg per actuation, for the maintenance treatment of asthma as prophylactic therapy in...
In a qualitative study of physicians managing patients with primary hyperoxaluria type 1 (PH1), presented at Kidney Week 2025, clinicians emphasized simplicity, patient convenience, and ease of...
A Stanford-led session offered clinicians a practical roadmap for integrating AI into primary care, highlighting foundational concepts, real-world applications, and a framework for evaluating AI tools based...
The Trump administration announced a new agreement with pharmaceutical companies Eli Lilly and Company and Novo Nordisk to reduce the cost of obesity medication and expand access to these treatments.
Primary care teams face mounting pressure to succeed under value-based payment models, but fragmented data and inconsistent information sharing remain major obstacles. The American Academy of Family...
Houston Methodist Hospital shows how artificial intelligence can be applied to post-discharge care, improving follow-up, reducing mortality, and creating a sustainable model for quality improvement. This...
Researchers evaluated the effectiveness of four large language models to determine which tool provided the most accurate, relevant, and consistent postoperative care instructions for patients who underwent...
Managing HIV today means balancing speed, precision, and prevention. From deciding when to start antiretroviral therapy (ART) to optimizing follow-up labs and ensuring vaccine and prophylaxis coverage,...
From respiratory syncytial virus monoclonal antibody approvals to thimerosal-free vaccine preferences, ACIP’s latest guidance has important implications for your practice.
